BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30486313)

  • 1. Perturbations in Traffic: Aberrant Nucleocytoplasmic Transport at the Heart of Neurodegeneration.
    Fahrenkrog B; Harel A
    Cells; 2018 Nov; 7(12):. PubMed ID: 30486313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD.
    Khalil B; Linsenmeier M; Smith CL; Shorter J; Rossoll W
    Mol Neurodegener; 2024 Jan; 19(1):8. PubMed ID: 38254150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy.
    Khalil B; Chhangani D; Wren MC; Smith CL; Lee JH; Li X; Puttinger C; Tsai CW; Fortin G; Morderer D; Gao J; Liu F; Lim CK; Chen J; Chou CC; Croft CL; Gleixner AM; Donnelly CJ; Golde TE; Petrucelli L; Oskarsson B; Dickson DW; Zhang K; Shorter J; Yoshimura SH; Barmada SJ; Rincon-Limas DE; Rossoll W
    Mol Neurodegener; 2022 Dec; 17(1):80. PubMed ID: 36482422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 and FUS en route from the nucleus to the cytoplasm.
    Ederle H; Dormann D
    FEBS Lett; 2017 Jun; 591(11):1489-1507. PubMed ID: 28380257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the impact of disrupted nucleocytoplasmic transport systems in
    McGoldrick P; Robertson J
    Front Cell Neurosci; 2023; 17():1247297. PubMed ID: 37720544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence?
    Hutten S; Dormann D
    Semin Cell Dev Biol; 2020 Mar; 99():151-162. PubMed ID: 31152789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant Huntingtin Disrupts the Nuclear Pore Complex.
    Grima JC; Daigle JG; Arbez N; Cunningham KC; Zhang K; Ochaba J; Geater C; Morozko E; Stocksdale J; Glatzer JC; Pham JT; Ahmed I; Peng Q; Wadhwa H; Pletnikova O; Troncoso JC; Duan W; Snyder SH; Ranum LPW; Thompson LM; Lloyd TE; Ross CA; Rothstein JD
    Neuron; 2017 Apr; 94(1):93-107.e6. PubMed ID: 28384479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Nucleocytoplasmic Transport Defects in Neurodegenerative Diseases.
    Boehringer A; Bowser R
    Adv Neurobiol; 2018; 20():85-101. PubMed ID: 29916017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hitchhiker's Guide to Nucleocytoplasmic Trafficking in Neurodegeneration.
    Moore S; Rabichow BE; Sattler R
    Neurochem Res; 2020 Jun; 45(6):1306-1327. PubMed ID: 32086712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models.
    Tauffenberger A; Chitramuthu BP; Bateman A; Bennett HP; Parker JA
    Hum Mol Genet; 2013 Feb; 22(4):782-94. PubMed ID: 23172908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered mRNP granule dynamics in FTLD pathogenesis.
    Bowden HA; Dormann D
    J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation.
    Hofweber M; Hutten S; Bourgeois B; Spreitzer E; Niedner-Boblenz A; Schifferer M; Ruepp MD; Simons M; Niessing D; Madl T; Dormann D
    Cell; 2018 Apr; 173(3):706-719.e13. PubMed ID: 29677514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis.
    Shang Y; Huang EJ
    Brain Res; 2016 Sep; 1647():65-78. PubMed ID: 27033831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired protein degradation in FTLD and related disorders.
    Götzl JK; Lang CM; Haass C; Capell A
    Ageing Res Rev; 2016 Dec; 32():122-139. PubMed ID: 27166223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
    Zhang K; Grima JC; Rothstein JD; Lloyd TE
    Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted nuclear import of cell cycle proteins in Huntington's/PolyQ disease causes neurodevelopment defects in cellular and Drosophila model.
    Dubey SK; Lloyd TE; Tapadia MG
    Heliyon; 2024 Feb; 10(4):e26393. PubMed ID: 38434042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered nucleocytoplasmic proteome and transcriptome distributions in an in vitro model of amyotrophic lateral sclerosis.
    Kim JE; Hong YH; Kim JY; Jeon GS; Jung JH; Yoon BN; Son SY; Lee KW; Kim JI; Sung JJ
    PLoS One; 2017; 12(4):e0176462. PubMed ID: 28453527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation.
    Tziortzouda P; Van Den Bosch L; Hirth F
    Nat Rev Neurosci; 2021 Apr; 22(4):197-208. PubMed ID: 33654312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.
    Naskar A; Nayak A; Salaikumaran MR; Vishal SS; Gopal PP
    Front Mol Neurosci; 2023; 16():1242925. PubMed ID: 37720552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.